Epstein-Barr virus: Difference between revisions
From IDWiki
m (Aidan moved page Epstein–Barr virus to Epstein-Barr virus) |
No edit summary |
||
Line 1: | Line 1: | ||
= Diagnosis = |
== Diagnosis == |
||
* '''Anti-VCA''' (viral capsid antigens): most useful |
* '''Anti-VCA''' (viral capsid antigens): most useful |
||
Line 9: | Line 9: | ||
* '''Monospot''' test: cross-reacts with many other conditions, and is often falsely negative in children |
* '''Monospot''' test: cross-reacts with many other conditions, and is often falsely negative in children |
||
== Serology in immunocompetent hosts == |
=== Serology in immunocompetent hosts === |
||
![Graph of serology](EBV serology.jpg) |
![Graph of serology](EBV serology.jpg) |
||
Line 60: | Line 60: | ||
|} |
|} |
||
== Serology in EBV-associated diseases == |
=== Serology in EBV-associated diseases === |
||
{| |
{| |
Revision as of 19:30, 15 August 2019
Diagnosis
- Anti-VCA (viral capsid antigens): most useful
- Anti-VCA IgM: appears early and disappears within 4 to 6 weeks
- Anti-VCA IgG: appears in acute phase, peaks at 2 to 4 weeks, then declines but remains positive for life
- Anti-EA (early antigen) IgG: appears in acute phase and falls to undetectable within 3 to 6 months (but may persist for years)
- Least useful test
- Anti-EBNA (EBV nuclear antigen): negative during acute phase converts after 2 to 4 months and stays positive for life
- Monospot test: cross-reacts with many other conditions, and is often falsely negative in children
Serology in immunocompetent hosts
![Graph of serology](EBV serology.jpg)
VCa-IgM | VCA-IgG | EBNA-IgG | Interpretation |
---|---|---|---|
– | – | – | Susceptible |
– | – | + | Past infection or non-specific |
– | + | – | Acute or past infection |
– | + | + | Past infection |
+ | – | – | Acute infection or non-specific |
+ | – | + | ?? |
+ | + | – | Acute infection |
+ | + | + | Late primary infection or reactivation |
Serology in EBV-associated diseases
Disease | VCA-IgM | VCA-IgG | VCA-IgA | EA(D)-IgG | EA(R)-IgG | EA-IgA | EBNA-IgG |
---|---|---|---|---|---|---|---|
Chronic active infection | ± | ++ | ± | + | ++ | – | ± |
Burkitt lymphoma | – | ++ | – | ± | ++ | – | + |
ENT carcinoma | – | ++ | + | ++ | ± | + | + |
Hodgkin lymphoma | – | ++ | – | + | – | – | + |
Reactivation | ± | ++ | ± | + | ± | ± | ± |
References
- ^ Massimo De Paschale. Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. World Journal of Virology. 2012;1(1):31. doi:10.5501/wjv.v1.i1.31.